1 – 9 of 9
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2015
- 
                        Mark
        Does Low-Molecular-Weight Heparin Influence the Antimyeloma Effects of Thalidomide? A Retrospective Analysis of Data from the GIMEMA, Nordic and Turkish Myeloma Study Groups
    
    - Contribution to journal › Article
 
- 
                        Mark
        The natural history of occult or angiodysplastic gastrointestinal bleeding in von Willebrand disease
    
    - Contribution to journal › Article
 
- 2008
- 
                        Mark
        Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
    
    - Contribution to journal › Article
 
- 2004
- 
                        Mark
        Early response predicts thalidomide efficiency in patients with advanced multiple myeloma
    
    - Contribution to journal › Article
 
- 
                        Mark
        Low serum level of soluble tumor necrosis factor receptor p55 predicts response to thalidomide in advanced multiple myeloma
    
    - Contribution to journal › Article
 
- 2003
- 
                        Mark
        Thalidomide inhibits early atherogenesis in apoE-deficient mice
    (2003) In APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 111(Suppl.). p.113-116- Contribution to journal › Article
 
- 2001
- 
                        Mark
        Clinical pharmacology of thalidomide
    
    - Contribution to journal › Article
 
- 1997
- 
                        Mark
        Experimental modulation and suppression of anti-allograft immune response
    (1997)- Thesis › Doctoral thesis (compilation)
 
- 
                        Mark
        Pharmacokinetics of the enantiomers of thalidomide
    (1997)- Thesis › Doctoral thesis (compilation)